Stock ONWD ONWARD MEDICAL N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Onward Medical N.V.

Equities

ONWD

NL0015000HT4

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:04 2024-05-27 am EDT 		5-day change 1st Jan Change
5.26 EUR +1.15% Intraday chart for Onward Medical N.V. +6.91% +69.68%
May. 20 Onward Medical N.V. Announces Publication of Global Up-Lift Pivotal Trial Results in Nature Medicine CI
Apr. 25 Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Breakthrough in treatment of spinal cord injury: significantly improved hand and arm function with ONWARD® ARC-EX® Therapy
AQ
Onward Medical N : – Company Presentation (May 2024)
PU
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
GL
ONWARD Medical provides breakthrough treatment for patients with partial spinal cord injury
AQ
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication
GL
Onward Medical N : Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC EX® Therapy
PU
Onward Medical N : – Company Presentation (May 2024)
PU
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
GL
ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
GL
Onward Medical N : Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
PU
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
GL
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
AQ
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
GL
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
AQ
ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
GL
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
GL
Onward Medical N : ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
PU
ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
GL
ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
AQ
Onward Medical N : D.L. Marver - Onward Medical N.V. - Eindhoven
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ONWD Stock
  4. News Onward Medical N.V.
  5. Press Releases